(1 reference)-
- 抗原 See all FMR1 抗体
- FMR1 (Fragile X Mental Retardation 1 (FMR1))
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This FMR1 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
- 纯化方法
- Ascitic fluid
- 免疫原
- Purified recombinant fragment of human FMR1 expressed in E. Coli.
- 克隆位点
- 4G9
- 亚型
- IgG1
- Top Product
- Discover our top product FMR1 Primary Antibody
-
anti-Fragile X Mental Retardation 1 (FMR1) antibody
FMR1 适用: 人 WB, IHC, IF, IHC (p), FACS 宿主: 小鼠 Monoclonal 3B4 unconjugated
anti-Fragile X Mental Retardation 1 (FMR1) (AA 36-279) antibodyFMR1 适用: 人, 小鼠, 大鼠, 犬, 猴 WB, IHC, IF, IHC (p), FACS 宿主: 小鼠 Monoclonal 1C6 unconjugated
anti-Fragile X Mental Retardation 1 (FMR1) (AA 26-279) antibodyFMR1 适用: 人, 小鼠, 大鼠, 犬, 猴 WB, IHC, IHC (p) 宿主: 小鼠 Monoclonal 2C3 unconjugated
anti-Fragile X Mental Retardation 1 (FMR1) (AA 121-220) antibodyFMR1 适用: 人 WB, ELISA, RNAi 宿主: 小鼠 Monoclonal 2D4 unconjugated
anti-Fragile X Mental Retardation 1 (FMR1) (AA 1-290) antibodyFMR1 适用: 人 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Fragile X Mental Retardation 1 (FMR1) (AA 500-600) antibodyFMR1 适用: 人 WB, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Fragile X Mental Retardation 1 (FMR1) antibodyFMR1 适用: 人 WB, IHC 宿主: 兔 Monoclonal unconjugated
anti-Fragile X Mental Retardation 1 (FMR1) (AA 121-220) antibodyFMR1 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 3E11 unconjugated
anti-Fragile X Mental Retardation 1 (FMR1) (AA 116-130) antibodyVerified FMR1 适用: 人 WB, IHC, ELISA 宿主: 山羊 Polyclonal unconjugated
anti-Fragile X Mental Retardation 1 (FMR1) antibodyFMR1 适用: 人 WB, IHC, ELISA, ICC 宿主: 小鼠 Monoclonal 4G9 unconjugated
-
- 应用备注
-
Western Bloting: 1/500 - 1/2000.
Immunohistochemistry: 1/200 - 1/1000.
Immunofluorescence: 1/200 - 1/1000.
ELISA: Propose dilution 1/10000.
Not yet tested in other applications.
Determining optimal working dilutions by titration test. - 限制
- 仅限研究用
-
- 状态
- Liquid
- 储存液
- Sodium azide
- 注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C
-
-
: "Identifying intrinsic and extrinsic determinants that regulate internal initiation of translation mediated by the FMR1 5' leader." in: BMC molecular biology, Vol. 9, pp. 89, (2008) (PubMed).
-
: "Identifying intrinsic and extrinsic determinants that regulate internal initiation of translation mediated by the FMR1 5' leader." in: BMC molecular biology, Vol. 9, pp. 89, (2008) (PubMed).
-
- 抗原
- FMR1 (Fragile X Mental Retardation 1 (FMR1))
- 别名
- FMR1 (FMR1 产品)
- 别名
- AT24755 antibody, BcDNA:GM08679 antibody, CG6203 antibody, Dmel\\CG6203 antibody, EP(3)3517 antibody, FMR antibody, FMR1 antibody, FMRP antibody, FMRp antibody, FXR antibody, Fmrp antibody, cg6203 antibody, dFMR antibody, dFMR1 antibody, dFMRP antibody, dFXR antibody, dFXR1 antibody, dFXRP antibody, dFmr1 antibody, dFmrp antibody, dfmr antibody, dfmr1 antibody, dfxr antibody, dfxr1 antibody, dmfr1 antibody, fmr antibody, fmr1 antibody, FRAXA antibody, POF antibody, POF1 antibody, zFMR1 antibody, Fmr-1 antibody, CG6203 gene product from transcript CG6203-RC antibody, fragile X mental retardation 1 antibody, fragile X mental retardation syndrome 1 antibody, Fmr1 antibody, FMR1 antibody, fmr1 antibody
- 背景
-
FMR1, also known as POF, FMRP, FRAXA. Entrez Protein: NP_002015. It is an RNA-binding protein that associates with polyribosomes and is a likely component of a messenger ribonuclear protein (mRNP) particle The protein may be involved in mRNA trafficking from the nucleus to the cytoplasm. A trinucleotide repeat (CGG) in the 5' UTR is normally found at 6-53 copies, but an expansion to 55-230 repeats is the cause of fragile X syndrome. Expansion of the trinucleotide repeat may also cause one form of premature ovarian failure (POF1). RNA-binding protein that plays a role in intracellular RNA transport and in the regulation of translation of target mRNAs.
Synonyms: POF, FMRP, POF1, FRAXA - 分子量
- 71kDa
- 基因ID
- 2332
- 途径
- Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
-
You are here:
